Clinical Trial Update: Gefitinib, Cisplatin, Irinotecan, and Radiation Therapy Before Surgery in Treating Patients With Esophageal Cancer or Gastroesophageal Junction Cancer That Can Be Removed By Surgery [Phase 1]

View source ↗

Summary

Phase 1 trial update of gefitinib with cisplatin and irinotecan (with radiation therapy) as neoadjuvant treatment for esophageal cancer or gastroesophageal junc…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Cancer
• Gastroesophageal Junction Cancer

Drugs mentioned

• CISPLATIN (cisplatin)
• Gefitinib (Gefitinib)
• Irinotecan (Irinotecan)

Snippet

Sponsor: University of California, San Francisco | Conditions: Esophageal Cancer | Phase 1 | Status: TERMINATED